Company / Free Cash Flow
Oric Pharmaceuticals, Inc. Free Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$111.7M
FY2025
5-year range
-$113.8M / -$60.5M
FY2021-FY2025
Trend
+1.9%
vs FY2024
Sector context
#112 of 194
Health Care
What the data says
At -$112M, Oric Pharmaceuticals, Inc.'s free cash flow ranks #112 of 194 in the Health Care sector. Free Cash Flow returned to growth in FY2025 after 6 years of decline, reaching -$112M.
Based on SEC 10-K filings.
-$112M in FY2025.
Declined from -$87M to -$112M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#112 of 194 in Health CareTop 58% of 194This company -$111.7M Sector average $470.6M
▼
-123.7% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 1.9% year-over-year.
- Ranks #112 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2018.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$111.7M | +1.9% |
| FY2024 | -$113.8M | -31.6% |
| FY2023 | -$86.5M | -12.1% |
| FY2022 | -$77.2M | -27.7% |
| FY2021 | -$60.5M | -31.7% |
| FY2020 | -$45.9M | -89.0% |
| FY2019 | -$24.3M | -14.6% |
| FY2018 | -$21.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026